Differential Expression of Plasma Proteins and Pathway Enrichments in Pediatric Diabetic Ketoacidosis

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2025 Jan 8

PMID 39773407

Authors

Paolo Spagnolo

Enis Cela

Maitray A Patel

David Tweddell

Mark Daley

Cheril Clarson

Saverio Stranges

Gediminas Cepinskas

Douglas D Fraser

Affiliations

Soon will be listed here.

Abstract

Background: In children with type 1 diabetes (T1D), diabetic ketoacidosis (DKA) triggers a significant inflammatory response; however, the specific effector proteins and signaling pathways involved remain largely unexplored. This pediatric case-control study utilized plasma proteomics to explore protein alterations associated with severe DKA and to identify signaling pathways that associate with clinical variables.

Methods: We conducted a proteome analysis of plasma samples from 17 matched pairs of pediatric patients with T1D; one cohort with severe DKA and another with insulin-controlled diabetes. Proximity extension assays were used to quantify 3072 plasma proteins. Data analysis was performed using multivariate statistics, machine learning, and bioinformatics.

Results: This study identified 214 differentially expressed proteins (162 upregulated, 52 downregulated; adj P < 0.05 and a fold change > 2), reflecting cellular dysfunction and metabolic stress in severe DKA. We characterized protein expression across various organ systems and cell types, with notable alterations observed in white blood cells. Elevated inflammatory pathways suggest an enhanced inflammatory response, which may contribute to the complications of severe DKA. Additionally, upregulated pathways related to hormone signaling and nitrogen metabolism were identified, consistent with increased hormone release and associated metabolic processes, such as glycogenolysis and lipolysis. Changes in lipid and fatty acid metabolism were also observed, aligning with the lipolysis and ketosis characteristic of severe DKA. Finally, several signaling pathways were associated with clinical biochemical variables.

Conclusions: Our findings highlight differentially expressed plasma proteins and enriched signaling pathways that were associated with clinical features, offering insights into the pathophysiology of severe DKA.

References

Svart M, Kampmann U, Voss T, Pedersen S, Johannsen M, Rittig N . Combined Insulin Deficiency and Endotoxin Exposure Stimulate Lipid Mobilization and Alter Adipose Tissue Signaling in an Experimental Model of Ketoacidosis in Subjects With Type 1 Diabetes: A Randomized Controlled Crossover Trial. Diabetes. 2016; 65(5):1380-6. DOI: 10.2337/db15-1645. View

Miller M, Robinson M, Fischer L, DiBattista A, Patel M, Daley M . Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics. Front Neurol. 2022; 12:787480. PMC: 8721148. DOI: 10.3389/fneur.2021.787480. View

Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen S, Ekman D . Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014; 9(4):e95192. PMC: 3995906. DOI: 10.1371/journal.pone.0095192. View

Ghetti S, Kuppermann N, Rewers A, Myers S, Schunk J, Stoner M . Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes. Diabetes Care. 2020; 43(11):2768-2775. PMC: 7576431. DOI: 10.2337/dc20-0187. View

Patel M, Fraser D, Daley M, Cepinskas G, Veraldi N, Grazioli S . The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis. Mol Med. 2024; 30(1):51. PMC: 11022403. DOI: 10.1186/s10020-024-00806-x. View

Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S . Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011; 39(15):e102. PMC: 3159481. DOI: 10.1093/nar/gkr424. View

Kraut J, Madias N . Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010; 6(5):274-85. DOI: 10.1038/nrneph.2010.33. View

Bialo S, Agrawal S, Boney C, Quintos J . Rare complications of pediatric diabetic ketoacidosis. World J Diabetes. 2015; 6(1):167-74. PMC: 4317308. DOI: 10.4239/wjd.v6.i1.167. View

Kitabchi A, Stentz F, Umpierrez G . Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun. 2004; 315(2):404-7. DOI: 10.1016/j.bbrc.2004.01.065. View

10.

Brisson A, Matsui D, Rieder M, Fraser D . Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2011; 129(1):153-62. DOI: 10.1542/peds.2011-0134. View

11.

Rochfort K, Collins L, McLoughlin A, Cummins P . Tumour necrosis factor-α-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6. J Neurochem. 2015; 136(3):564-72. DOI: 10.1111/jnc.13408. View

12.

Aon M, Aoun A, Alshami A, Alharbi A, Alshammari F, Alnajjar M . Association of the systemic immune-inflammation index (SII) and severity of diabetic ketoacidosis in patients with type 1 diabetes mellitus: a retrospective cohort study. Ann Med Surg (Lond). 2024; 86(7):3865-3872. PMC: 11230746. DOI: 10.1097/MS9.0000000000002185. View

13.

Woo M, Patterson E, Cepinskas G, Clarson C, Omatsu T, Fraser D . Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis. Pediatr Res. 2015; 79(2):295-300. DOI: 10.1038/pr.2015.215. View

14.

Voss T, Vendelbo M, Kampmann U, Pedersen S, Nielsen T, Johannsen M . Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis. Diabetologia. 2018; 62(3):494-503. DOI: 10.1007/s00125-018-4785-x. View

15.

Mohammad M, Saeed R, Mohammed A, Khalique A, Hamad M, El-Huneidi W . plays a critical role in insulin secretion in INS-1 cells and human pancreatic islets. Exp Biol Med (Maywood). 2023; 248(4):339-349. PMC: 10159522. DOI: 10.1177/15353702221146552. View

16.

Xu G, Chen J, Jo S, Grayson T, Ramanadham S, Koizumi A . Deletion of Gdf15 Reduces ER Stress-induced Beta-cell Apoptosis and Diabetes. Endocrinology. 2022; 163(5). PMC: 9272264. DOI: 10.1210/endocr/bqac030. View

17.

Fahey E, Doyle S . IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis. Front Immunol. 2019; 10:1426. PMC: 6603210. DOI: 10.3389/fimmu.2019.01426. View

18.

Hoffman W, Cudrici C, Boodhoo D, Tatomir A, Rus V, Rus H . Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis. Exp Mol Pathol. 2019; 108:97-104. PMC: 6563901. DOI: 10.1016/j.yexmp.2019.04.008. View

19.

Glass C, Olefsky J . Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012; 15(5):635-45. PMC: 4156155. DOI: 10.1016/j.cmet.2012.04.001. View

20.

Ahmed K, Tunaru S, Tang C, Muller M, Gille A, Sassmann A . An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab. 2010; 11(4):311-9. DOI: 10.1016/j.cmet.2010.02.012. View